Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Centocor ties into GeneNews osteoarthritis program
January 2009
SHARING OPTIONS:

TORONTO—GeneNews Ltd., a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, in December entered into a agreement allowing Centocor Research & Development Inc. selected access to research from its osteoarthritis genomic biomarker program. Centocor is a biomedicine-oriented company that seeks innovative ways to treat cancer and immune-mediated inflammatory disorders, such as rheumatoid arthritis and plaque psoriasis. Financial and other terms of the agreement were not disclosed. DDN

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.